Shareholder proposals targeting corporate diversity, equity, and inclusion (DEI) initiatives have surged across Russell 3000 companies in the 2025 proxy season. According to a new analysis powered by the CompanyIQ® corporate research platform, these “anti-DEI” proposals more than doubled in the 2025 proxy year compared to previous years—yet none have passed, garnering on average just…
Using the MyLogIQ CompanyIQ research platform, we analyzed the proxy statements of Russell 3000 companies from 2022-2024 for artificial intelligence (AI)-related shareholder proposals. Among our findings are: 13 AI shareholders proposals were submitted in 2024. That’s a threefold increase from the 2023 proxy season. More than 50% of the 2024 AI shareholder proposals were sponsored…
After the Supreme Court issued its ruling on Dobbs v. Jackson Women’s Health Organization last year, the case that overturned Roe v. Wade, companies were suddenly thrust into the spotlight on abortion and pressured to make difficult choices regarding reproductive health care and their workforces. Now, investors on both sides of the issue are using…
Delaware companies have been given the green light to protect corporate officers from personal monetary liability in breach of fiduciary duty claims after the state adopted new amendments to its corporate law provisions in August. But to make use of the provisions, known as officer exculpation, companies will have to update their charters and gain…
Companies including Altria Group, CVS Health and Intel are the latest to have failed say on pay so far this proxy season, as investors zero in on longtime compensation issues that have been magnified by the coronavirus pandemic. Indeed, investors are carefully scrutinizing how pay, strategy and performance will align to weather the storm. Shareholders may react to perceived failings…